Three Black Friday Tips for Choosing a Health Insurance Plan

With Black Friday just a few days away, holiday shopping madness is kicking into full gear. Deciding what to buy, comparing prices and ultimately making a decision can be stressful. The best advice...
Read More
The U.S.– India Relationship is Full of Opportunities

Today, United States Trade Representative Michael Froman is in India to participate in the U.S. – India Trade Policy Forum. Since Indian Prime Minister Narendra Modi’s election in May, Indian and...
Read More
A Look at How to Best Promote Healthy Lifestyles and Adherence to Diabetes Medication

Every November is Diabetes Awareness Month – a time to reflect on the progress we have made in treating the nearly 26 million Americans with the chronic disease. We take stock of new treatments,...
Read More
Week in Review: Collaboration for Patient Progress

Ryan Hohman of Friends of Cancer Research authored a guest post this week that echoed our own thoughts stating, “Open collaboration is often the best route to innovation and improved outcomes for...
Read More
ICYMI: New Study Highlights Often High Out-of-Pocket Costs in Exchanges

Earlier this week, the Kaiser Family Foundation released new research about the deductibles in different health insurance exchange plans. The study found for bronze or silver plans patients often...
Read More
Lung-MAP Demonstrates Real Change in Cancer Research and Care Possible through Collaboration

November is National Lung Cancer Awareness Month, a time to reflect upon the disease’s enormous human cost. This month, some 18,600 Americans will be diagnosed with lung cancer and approximately...
Read More
Putting the IMS Health Global Forecast on Prescription Medicines in Perspective

Since 2000, biopharmaceutical companies have brought more than 450 new innovative medicines to the U.S. market, resulting in significant progress against some of the most costly and challenging...
Read More
The Cost of Innovation

Patients are living longer, healthier lives thanks to biopharmaceutical innovation. But, as evidenced by a new study released yesterday by the Tufts Center for the Study of Drug Development, the road...
Read More
Real Change for Patients with GI Cancer

“Unless someone like you cares a whole awful lot, nothing is going to get better. It’s not.” Real change and progress, as Dr. Seuss suggests, starts with passionate individuals who want to make a...
Read More
Responsible Clinical Trial Data Sharing Is Enhancing Science and Improving Patient Health

The discovery and development of new medicines for patients is a comprehensive, data-driven process that requires years of research. At the heart of this endeavor is the clinical trial, the rigorous...
Read More
New Polling: When It Comes to Health Insurance Coverage, What Most Concerns You?

This morning, PhRMA joined Morning Consult to host a panel of experts discussing where health care coverage stands now and where we need to go. The conversation was spurred by a recent poll Morning...
Read More
Working Together to Stop Ebola in its Tracks

The fantastic news came yesterday that Dr. Craig Spencer, the last patient in the U.S. with Ebola, has been cured. While this development certainly inspires hope, there is still much to be done in...
Read More
What Are Health Insurance Exchanges?

You’ve probably heard about the Affordable Care Act, health insurance exchanges or even the health insurance marketplace. But what does it all mean? Health insurance exchanges or the marketplace...
Read More
I’m Not Average: Pancreatic Cancer Survivor Who Defies the Odds

According to his doctor, Warren Littrel should have died several years ago. Instead, Warren recently celebrated his fifth anniversary of his diagnosis of stage IV pancreatic cancer. Before the...
Read More
Debunking the Myths of Treating Hepatitis C

Original publish date was 7/21/2014; this post was updated on 8/5/2014 and 11/4/2014. A national dialogue is needed around the value of new medicines and cures and the role they play in improving...
Read More